1. Home
  2. AZTA vs SPTX Comparison

AZTA vs SPTX Comparison

Compare AZTA & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$24.51

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$21.26

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AZTA
SPTX
Founded
1978
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
AZTA
SPTX
Price
$24.51
$21.26
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$40.60
N/A
AVG Volume (30 Days)
706.6K
212.0K
Earning Date
05-06-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
60.52
N/A
EPS
N/A
N/A
Revenue
$593,821,000.00
N/A
Revenue This Year
$6.99
N/A
Revenue Next Year
$5.98
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.93
$17.59
52 Week High
$41.73
$22.98

Technical Indicators

Market Signals
Indicator
AZTA
SPTX
Relative Strength Index (RSI) 56.08 59.79
Support Level $21.88 N/A
Resistance Level $32.99 $22.98
Average True Range (ATR) 1.17 1.76
MACD 0.06 -0.05
Stochastic Oscillator 51.78 46.24

Price Performance

Historical Comparison
AZTA
SPTX

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: